|
Jeffrey L. Quillen Partner Boston 617 832 1205 direct 617 832 7000 fax Email Jeffrey Quillen’s varied business law practice focuses on companies involved with advanced technology applications. He serves as outside general counsel to a number of emerging biotechnology, software and information technology companies. For these and other clients he negotiates and drafts agreements regarding intellectual property rights, including patent license agreements with major research universities and collaboration agreements with pharmaceutical companies. On the financing side, Jeffrey represents venture capital funds and emerging companies in venture capital financing transactions, including private placements of convertible preferred stock and subordinated debt. He also advises borrowers and lenders on such commercial lending and leasing arrangements as liens of credit, secured credit arrangements and project financings. Finally, Jeffrey represents buyers and sellers in mergers and acquisitions, involving public and private companies. His work in this area includes helping foreign companies to acquire U.S. companies and organize international operations. Bars and Court Admissions District of Columbia Massachusetts Florida professional / civic involvement Boston Bar Association, Member SPEECHES AND CONFERENCES Panelist, William Gallagher Associates Conference, "Clinical Trials: Managing the Risk, Managing Expectations," November 28, 2007 Moderator, Massachusetts Biotechnology Council, Annual Investors Conference, "The Coming Wave…Nanobiotechnology," November 8, 2007 Panelist, MIT Enterprise Forum of Cambridge Start-up Clinic, October 3, 2007 Moderator, BIO International Convention, "Get Smart: Successful Strategies for Negotiating with Research Institutions," May 8, 2007 American Conference Institute Life Sciences Conference, “Structuring the Milestone-Based Life Sciences Acquisition: Tails, Taxes and Control,” March 14-15, 2007 American Conference Institute IP Due Diligence Conference, “A Buyer’s Guide to Managing the Due Diligence Process,” January 30-31, 2006 and June 26-27, 2006 Moderator, Harvard Medical School Early-Stage Life Sciences Technology Conference II, May 1, 2006 publications Top five things to consider when negotiating an R&D partnership, MASS HIGH TECH (January 17-23, 2005) Costs and Benefits of Scientific Advisory Boards, FORUM REPORTER - THE NEWSLETTER OF THE MIT ENTERPRISE FORUM OF CAMBRIDGE (February 2004) Creative Use of Milestones Can Unlock Venture Capital, FORUM REPORTER - THE NEWSLETTER OF THE MIT ENTERPRISE FORUM OF CAMBRIDGE (February 2003 | 